-
Signature
-
By: Yolanda Goettsch, Attorney-in-Fact For: Michael Kirban
-
Stock symbol
-
COCO
-
Transactions as of
-
Sep 14, 2023
-
Transactions value $
-
-$1,735,437
-
Form type
-
4
-
Date filed
-
9/18/2023, 06:49 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
COCO |
Common Stock |
Sale |
-$1.34M |
-45.3K |
-5.69% |
$29.59 |
750K |
Sep 14, 2023 |
by M. Kirban Revoc |
F1, F2, F3 |
transaction |
COCO |
Common Stock |
Sale |
-$395K |
-14.7K |
-1.96% |
$26.87 |
736K |
Sep 15, 2023 |
by M. Kirban Revoc |
F1, F3, F4 |
holding |
COCO |
Common Stock |
|
|
|
|
|
61.3K |
Sep 14, 2023 |
Direct |
|
holding |
COCO |
Common Stock |
|
|
|
|
|
2.03M |
Sep 14, 2023 |
by M. Kirban 2010 |
F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
holding |
COCO |
Non-Qualified Stock Option (right to buy) |
|
|
|
|
|
546K |
Sep 14, 2023 |
Common Stock |
546K |
$10.18 |
Direct |
F6 |
holding |
COCO |
Non-Qualified Stock Option (right to buy) |
|
|
|
|
|
41K |
Sep 14, 2023 |
Common Stock |
41K |
$10.18 |
Direct |
F7 |
holding |
COCO |
Non-Qualified Stock Option (right to buy) |
|
|
|
|
|
299K |
Sep 14, 2023 |
Common Stock |
299K |
$15.00 |
Direct |
F8 |
holding |
COCO |
Non-Qualified Stock Option (right to buy) |
|
|
|
|
|
46.9K |
Sep 14, 2023 |
Common Stock |
46.9K |
$16.91 |
Direct |
F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: